E
ENDRA Life Sciences Inc. NDRA
$4.09 -$0.0519-1.25% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 8.36% 1.26% -14.39% 25.83% 21.79%
Total Depreciation and Amortization -24.68% -24.58% -25.10% -21.60% -12.11%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 149.29% 113.69% 224.92% 73.86% 8.14%
Change in Net Operating Assets 106.55% 105.35% 114.52% -1,278.42% -248.66%
Cash from Operations 38.01% 28.71% 22.50% 22.97% 18.99%
Capital Expenditure 24.45% 81.42% 52.80% 65.09% 71.55%
Sale of Property, Plant, and Equipment -100.00% -100.00% -65.22% -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -64.76% 70.70% 48.18% 83.99% 86.96%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 100.00% 100.00% -- -- --
Issuance of Common Stock -89.56% 7.21% 20.86% 45.75% 103.83%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 559.07% 546.27% 546.27% 38,227.36% 4,949.25%
Cash from Financing -90.51% -6.28% 3.87% 62.16% 123.81%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -390.40% 176.21% 119.25% 130.13% 124.48%